These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 4907894)
1. [Appearance of circulating, precipiting antibodies, horse antiproteins in patients with renal grafts treated with antilymphocyte serum]. Druet P; Bariéty J; Lagrue G; Idatte JM J Urol Nephrol (Paris); 1969 Dec; 75(12):999-1005. PubMed ID: 4907894 [No Abstract] [Full Text] [Related]
2. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin. Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090 [TBL] [Abstract][Full Text] [Related]
3. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. II. Purification of antibodies. Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH Laryngoscope; 1972 Feb; 82(2):252-64. PubMed ID: 4622551 [No Abstract] [Full Text] [Related]
4. The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients. Amemiya H; Yokoyama T; Putnam CW; Torisu M; Starzl TE Clin Exp Immunol; 1972 Mar; 10(3):417-26. PubMed ID: 4556008 [TBL] [Abstract][Full Text] [Related]
5. The immunogenic components of equine anti-human lymphocyte lobulin in renal allograft recipients. Wolf RE; Remmers AR; Sarles HE; Fish JC; Lindley JD; Vyvial TM; Ritzmann SE Clin Exp Immunol; 1972 Feb; 10(2):235-41. PubMed ID: 4558408 [TBL] [Abstract][Full Text] [Related]
6. Permanent survival of dog renal allografts after a limited course of antilymphocyte serum treatment. Shanfield I; Wren SF; Blennerhassett JB Surg Forum; 1969; 20():304-5. PubMed ID: 4910606 [No Abstract] [Full Text] [Related]
7. ALG treatment of Rhesus monkeys. Attempts to reduce complications by the induction of tolerance. Balner H; Yron I; Dersjant H; Zaalberg O; Betel I Transplantation; 1970 Nov; 10(5):416-24. PubMed ID: 4992451 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation. Cerilli GJ; Miller A; Hattan D Surg Forum; 1970; 21():250-2. PubMed ID: 4936976 [No Abstract] [Full Text] [Related]
9. Induction of tolerance to antilymphocyte globulin in man. Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL Transplant Proc; 1971 Mar; 3(1):754-7. PubMed ID: 4937967 [No Abstract] [Full Text] [Related]
11. Increasing effectiveness of antilymphocytic globulin by prevention of antibody formation to horse IgG. Butler WT; Rossen RD Transplant Proc; 1971 Mar; 3(1):733-6. PubMed ID: 4999467 [No Abstract] [Full Text] [Related]
12. Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response. Lucas ZJ; Markley J; Travis M Fed Proc; 1970; 29(6):2041-7. PubMed ID: 4921562 [No Abstract] [Full Text] [Related]
13. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum. Hasek M; Skamene E; Karakoz I; Chutná J; Nouza K; Bubeník J; Sovová V; Nĕmec M; Jonák J Folia Biol (Praha); 1968; 14(6):411-24. PubMed ID: 4236901 [No Abstract] [Full Text] [Related]
14. [Clinical use of antilymphocyte serum in organ and tissue allotransplantation (survey of the literature)]. Korenevskaia VA; Shumakov VI Khirurgiia (Mosk); 1972 Feb; 49(2):127-31. PubMed ID: 4572233 [No Abstract] [Full Text] [Related]